Research
Hormonal
Obesity medications (OMs) such as semaglutide and tirzepatide provide benefits for adiposity-related conditions independent of weight reduction.
If you are considering obesity medications, ask your doctor about their potential benefits beyond weight loss, such as reducing cardiovascular risk or improving sleep apnea. These benefits may be significant even if weight loss is modest.
StrongSupportsHIGH confidence
In addition to their capacity to reduce and maintain weight, some OMs provide benefits for adiposity-related conditions that are both dependent and independent of weight reduction.
Why this rating
Based on specific clinical trials (SELECT, etc.) cited in the paper.
Source
Chronicity of obesity and the importance of early treatment to reduce cardiometabolic risk and improve body composition
Sandra Christensen et al. · Obesity Pillars · 2025
narrative_reviewCited 11×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →